113 related articles for article (PubMed ID: 11483279)
1. Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery.
Oh YK; Kim JP; Hwang TS; Ko JJ; Kim JM; Yang JS; Kim CK
Vaccine; 2001 Aug; 19(31):4519-25. PubMed ID: 11483279
[TBL] [Abstract][Full Text] [Related]
2. Enhanced brain targeting efficiency of intranasally administered plasmid DNA: an alternative route for brain gene therapy.
Han IK; Kim MY; Byun HM; Hwang TS; Kim JM; Hwang KW; Park TG; Jung WW; Chun T; Jeong GJ; Oh YK
J Mol Med (Berl); 2007 Jan; 85(1):75-83. PubMed ID: 17089096
[TBL] [Abstract][Full Text] [Related]
3. Distribution fate and mechanism of immune modulation following mucosal delivery of plasmid DNA encoding IL-10.
Chun S; Daheshia M; Lee S; Eo SK; Rouse BT
J Immunol; 1999 Sep; 163(5):2393-402. PubMed ID: 10452973
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity, after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice.
Hinkula J; Hagbom M; Wahren B; Schroder U
Vaccine; 2008 Sep; 26(40):5101-6. PubMed ID: 18482783
[TBL] [Abstract][Full Text] [Related]
5. Intranasal delivery of plasmids expressing bovine herpesvirus 1 gB/gC/gD proteins by polyethyleneimine magnetic beads activates long-term immune responses in mice.
Liu XB; Yu GW; Gao XY; Huang JL; Qin LT; Ni HB; Lyu C
Virol J; 2021 Mar; 18(1):60. PubMed ID: 33743745
[TBL] [Abstract][Full Text] [Related]
6. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
[TBL] [Abstract][Full Text] [Related]
7. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
Khatri K; Goyal AK; Gupta PN; Mishra N; Vyas SP
Int J Pharm; 2008 Apr; 354(1-2):235-41. PubMed ID: 18182259
[TBL] [Abstract][Full Text] [Related]
8. Rapid and wide-reaching delivery of HIV-1 env DNA vaccine by intranasal administration.
Tadokoro K; Koizumi Y; Miyagi Y; Kojima Y; Kawamoto S; Hamajima K; Okuda K; Tanaka S; Onari K; Wahren B; Aoki I; Okuda K
Viral Immunol; 2001; 14(2):159-67. PubMed ID: 11398811
[TBL] [Abstract][Full Text] [Related]
9. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts.
Klavinskis LS; Barnfield C; Gao L; Parker S
J Immunol; 1999 Jan; 162(1):254-62. PubMed ID: 9886393
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and expression of targeted fusion anti-caries DNA vaccine pGJA-P/VAX in mice.
Liu C; Fan M; Xu Q; Li Y
J Gene Med; 2008 Mar; 10(3):298-305. PubMed ID: 18085725
[TBL] [Abstract][Full Text] [Related]
11. Skin permeation, biodistribution, and expression of topically applied plasmid DNA.
Kang MJ; Kim CK; Kim MY; Hwang TS; Kang SY; Kim WK; Ko JJ; Oh YK
J Gene Med; 2004 Nov; 6(11):1238-46. PubMed ID: 15459965
[TBL] [Abstract][Full Text] [Related]
12. The cellular basis of immune induction at mucosal surfaces by DNA vaccination.
Barnfield C; Brew R; Tilling R; Rae A; Wheeler C; Klavinskis LS
Dev Biol (Basel); 2000; 104():159-64. PubMed ID: 11713815
[TBL] [Abstract][Full Text] [Related]
13. Plasmid DNA-recombinant Opc protein complexes for nasal DNA immunization.
Musacchio A; Quintana D; Herrera AM; Sandez B; Alvarez JC; Falcón V; la Rosa MC; Alvarez F; Pichardo D
Vaccine; 2001 Jun; 19(27):3692-9. PubMed ID: 11395203
[TBL] [Abstract][Full Text] [Related]
14. Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization.
Sizemore DR; Branstrom AA; Sadoff JC
Vaccine; 1997 Jun; 15(8):804-7. PubMed ID: 9234519
[TBL] [Abstract][Full Text] [Related]
15. In vivo kinetics and biodistribution of a Hantaan virus DNA vaccine after intramuscular injection in mice.
Wang S; Nie Q; Zheng LY; Hu J; Luo EJ
Virol Sin; 2010 Jun; 25(3):177-82. PubMed ID: 20960291
[TBL] [Abstract][Full Text] [Related]
16. In vivo kinetics and biodistribution of a HIV-1 DNA vaccine after administration in mice.
Kim BM; Lee DS; Choi JH; Kim CY; Son M; Suh YS; Baek KH; Park KS; Sung YC; Kim WB
Arch Pharm Res; 2003 Jun; 26(6):493-8. PubMed ID: 12877561
[TBL] [Abstract][Full Text] [Related]
17. Plasmid DNA vaccines: tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA.
Manam S; Ledwith BJ; Barnum AB; Troilo PJ; Pauley CJ; Harper LB; Griffiths TG; Niu Z; Denisova L; Follmer TT; Pacchione SJ; Wang Z; Beare CM; Bagdon WJ; Nichols WW
Intervirology; 2000; 43(4-6):273-81. PubMed ID: 11251382
[TBL] [Abstract][Full Text] [Related]
18. Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice.
Iqbal M; Lin W; Jabbal-Gill I; Davis SS; Steward MW; Illum L
Vaccine; 2003 Mar; 21(13-14):1478-85. PubMed ID: 12615444
[TBL] [Abstract][Full Text] [Related]
19. Intranasal administration of human immunodeficiency virus type-1 (HIV-1) DNA vaccine with interleukin-2 expression plasmid enhances cell-mediated immunity against HIV-1.
Xin KQ; Hamajima K; Sasaki S; Honsho A; Tsuji T; Ishii N; Cao XR; Lu Y; Fukushima J; Shapshak P; Kawamoto S; Okuda K
Immunology; 1998 Jul; 94(3):438-44. PubMed ID: 9767429
[TBL] [Abstract][Full Text] [Related]
20. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
Morello CS; Cranmer LD; Spector DH
J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
